Related Experiment Video
Updated: Aug 14, 2026
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Concurrent presentation of erythrocytic and megakaryocytic aplasia
B F Canavan1, R D Huhn, H C Kim
1Division of Hematology/Oncology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, USA.
Insights
Idiopathic concurrent erythrocytic and megakaryocytic aplasia suggests an immune cause. This case offers clinical evidence supporting a link between red blood cell and platelet precursor cell lines.
Area of Science:
- Hematology
- Immunology
- Stem Cell Biology
Background:
- Idiopathic concurrent erythrocytic and megakaryocytic aplasia is a rare condition affecting blood cell production.
- Understanding the underlying mechanisms is crucial for effective treatment strategies.
Observation:
- A patient presented with simultaneous aplasia of red blood cell and megakaryocyte lineages.
- Bone marrow pathology and response to immunosuppressive therapy indicated an immune-mediated process.
Findings:
- Erythroid colony growth was not suppressed, suggesting specific immune targets.
- The case provides clinical evidence for a relationship between erythrocytic and megakaryocytic cell lines.
- This relationship may involve shared bipotential stem cells or cell surface markers.
Implications:
- The findings support an immune etiology for concurrent aplasia of these cell lines.
- This strengthens the hypothesis of shared developmental pathways or markers between red blood cells and platelets.
- Further research into immune mechanisms and stem cell interactions is warranted.
Abstract:
A case of a patient presenting with idiopathic concurrent erythrocytic and megakaryocytic aplasia is reported. The patient's response to immunosuppressive therapy and her bone marrow pathology clearly suggest an immune mechanism. Based on the lack of suppression of erythroid colony growth, several mechanisms are postulated. Well-established molecular and genetic evidence, along with clinical observations, suggests that a relationship exists between the erythrocytic and megakaryocytic cell lines. This may be related to a common bipotential stem cell or common cell surface markers. This case provides strong clinical evidence to support this relationship.
More Related Videos
Related Concept Videos
01:14Erythropoiesis
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...